# PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Study · id `cardio:ct-nct04089059` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04089059](<https://clinicaltrials.gov/study/NCT04089059>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04089059

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 738 participants.

## Technical summary

Registry record NCT04089059. Allocation not applicable; no masking; primary purpose diagnostic. Start 2020-01-10 (actual); primary completion 2028-04 (anticipated). Results posted on 2025-03-03.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 738 participants (enrolled count; ClinicalTrials.gov record NCT04089059, source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)
- Started: 2020-01-10 (actual) (ClinicalTrials.gov record NCT04089059, source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)
- Primary completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT04089059, source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)
- Completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT04089059, source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)
- Results first posted: 2025-03-03 (ClinicalTrials.gov record NCT04089059, source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)
- Countries: United States; Belgium; Ireland (ClinicalTrials.gov record NCT04089059, source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04089059-2026-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
- Acronym: PROACTIVE-HF
- Condition: Heart Failure NYHA Class III
- Intervention (Device): Cordella™ Pulmonary Artery Sensor System
- Lead sponsor: Endotronix, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: a2f9720a859dddce98612cbd8fdf41a5874c904601a73944c520b55fae9f3d30
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
